Navigation Links
Nanomedicine Company Focuses on Improving Premature Infant Health and Reducing Death Rate

NanoStar™ Health Corporation today announced its sole focus of delivering novel nanotechnology solutions for instantly assessing the metabolic health of the nearly 13 million premature infants born throughout the world, without requiring a costly, complex medical infrastructure.

Santa Barbara, CA (PRWEB) October 6, 2009 -- NanoStar™ Health Corporation today announced its sole focus of delivering novel nanotechnology solutions for instantly assessing the metabolic health of the nearly 13 million premature infants born throughout the world, without requiring a costly, complex medical infrastructure.

The global prevalence of preterm births, defined as less than 37 weeks gestation, is 9.6 percent. In decreasing order of prevalence, these births occur in Africa, North America (defined as the United States and Canada), Asia, Latin America and the Caribbean, Oceania (Australia and New Zealand), and Europe. Additionally, the prevalence of preterm births is increasing. In the United States, it has increased 36 percent in the past 25 years. Health focused organizations such as the March of Dimes (, World Health Organization, and the U.S. National Institute of Health have recently identified strategies for improving the care and reducing the death rate of premature infants as top priorities.

"Because these infants are premature, their organs aren't fully developed, which places them at risk for maldevelopment or malfunction and susceptibility to the external world via infections and other health risks. It is key to assess their metabolic health in order to determine the best strategies for keeping these sick infants alive while they continue to develop to term," said Michael D. Black, MD, MBA, renowned congenital cardiac surgeon and Chief Medical Officer of NanoStar Health. "Unfortunately, today this is done by sticking the baby's heel with a scalpel to collect and analyze a blood sample every four to six hours. This method is not only a source of severe trauma, which has recently been linked to adult learning disabilities; but it is also the number one cause of anemia in these sick infants. This medically induced anemia leads to an average of over five blood transfusions per week with standard lab blood testing methods and over three transfusions with newer point-of-care blood testing, with each transfusion introducing additional health risks to these already ailing children," Black said.

"Nanotechnology offers the promise of delivering innovative methods of assessing and treating the health of preemies," said Nihat Okulan, PhD, and Chief Technology Officer of NanoStar Health. "Not only do nanotechnology products meet the size needs of pediatric patients, they also allow us to create new paradigms in clinical methodology including immediate test results utilizing significantly smaller sample sizes. For example, nano-sized devices, which are characterized by their high surface area and low sample
volume, allow for faster response times with the use of lower and safer concentrations of the respective samples," Okulan said.

"The focus of our product development at NanoStar Health is not only assessing the health of premature infants, but doing so in a way that does not further traumatize the infant or require a costly healthcare infrastructure. Therefore, these products will not only benefit the infants born in first-world countries, but in all countries including Africa and Asia where medical technology resources are scarce, but 85 percent of the nearly 13 million preemies are born yearly," said Anita Chambers, PhD, MBA, and Chief Operations Officer of NanoStar Health. "Providing healthcare options to underserved patient populations, while simultaneously reducing healthcare costs are the key tenets of our business, nanotechnology is our method of accomplishing this," Chambers said.

About NanoStar™ Health Corporation

NanoStar Health is positioned to become a global leader in the emerging technology arena of nanomedical devices specifically designed for premature infants. The Company began operations in March 2009 and was incorporated in May 2009 to capitalize on the founder's expertise in nanotechnology, neonatal and pediatric medicine, and medical device commercialization.

NanoStar Health founders include:

Michael D. Black, MD, MBA - Chief Medical Officer, a R.S. McLaughlin Fellow, is a practicing congenital cardiac surgeon (adult and pediatric). Currently Dr. Black is the Chief of Pediatric and Adult Congenital Heart Program at California Pacific Medical Center in San Francisco. Dr. Black was Chief of the Pediatric Heart Program from 1999 - 2003 at Stanford University School of Medicine and additionally a founding member of Bio-design consortium at Stanford University.

Anita Chambers PhD, MBA - Chief Operating Officer, a Fielding Institute for Social Innovation Founding Fellow, has nearly 25 years experience in the medical industry where she has successfully developed, commercialized and launched 26 medical devices including many "world's firsts." Her background includes clinical medicine expertise, social science expertise, and expertise in technology management.

Nihat Okulan PhD - Chief Technology Officer, is an expert in developing MicroElectroMechanical Systems (MEMS) and Nanotechnology for commercial and medical applications. He has conducted MEMS research and development for over ten years and has published numerous papers on MEMS devices and fabrication technologies. Many of Dr. Okulan's efforts have been directed towards the manufacturability of nano- and micro-devices.

Additional information is available at

Media Contact:
Anita Chambers, PhD, MBA
Chief Operating Officer
NanoStar Health Corporation
650-823-3014 (direct)


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Reportlinker Adds Nanomedicine Report
2. World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
3. NanoMedicine Summit Returns to Cleveland, September 25-26
5. CEO of Burrill & Company to Speak at BioConference Live Slated for November 17th and 18th
6. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
7. Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac
8. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
9. Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac
10. DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression
11. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
Post Your Comments:
(Date:12/1/2015)... -- Cepheid (Nasdaq: CPHD ) today announced that, ... Healthcare Conference in New York City ... outlook for the fourth quarter of 2015 and initiating ... term business model expectations. John Bishop , ... be the fastest growing company of the major market ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... practitioners and aesthetics professionals from Central America and abroad for the first Iberoamerican ... City, Panama Feb. 17-19, 2016. Testart will present and discuss new trends in ...
(Date:11/30/2015)... (NYSE: BIOA ), a leader in renewable materials, today ... Climate Pledge, alongside more than 140 companies from across the ... demonstrate an ongoing commitment to climate action and to voice ... Paris climate negotiations. Sarnia, Canada ... --> BioAmber uses biotechnology to convert renewable sugars ...
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 Paris ... 2015.   --> Paris from 17 ... DERMALOG, the biometrics innovation leader, has invented the first ... fingerprints on the same scanning surface. Until now two different ... Now one scanner can capture both on the same ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
Breaking Biology News(10 mins):